LATE-BREAKING ABSTRACT: A relative plasma Elafin deficiency in children with cystic fibrosis (CF) is associated with pulmonary disease Source: International Congress 2014 – Cystic fibrosis: genotypes, inflammation and microbiology Year: 2014
Increased systemic inflammation in cystic fibrosis (CF) is associated with deterioration in lung clearance index (LCI) Source: International Congress 2014 – Cystic fibrosis: genotypes, inflammation and microbiology Year: 2014
Cystic fibrosis transmembrane conductance regulator pharmacotherapy Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-46-6, page=88 Year: 2006
Cigarette smoke induces systemic defects in cystic fibrosis transmembrane conductance regulator (CFTR) ion transport Source: Annual Congress 2013 –Cystic fibrosis: basic and applied science Year: 2013
Regulation of interleukin-8 by miR-17 during chronic inflammation in cystic fibrosis Source: International Congress 2015 – The multiple faces of host defense Year: 2015
Atypical cystic fibrosis Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-46-6, page=38 Year: 2006
LATE-BREAKING ABSTRACT: The effects and mechanism of adiponectin on inhibiting pulmonary fibrosis Source: International Congress 2014 – ILDs 1 Year: 2014
Polymorphisms in NOS-1 and NOS-3 genes may influence the cystic fibrosis severity? Source: International Congress 2014 – Cystic fibrosis: genotypes, inflammation and microbiology Year: 2014
Lung clearance index predicts pulmonary exacerbations in cystic fibrosis Source: International Congress 2014 – Cystic fibrosis: clinical assessment and treatment Year: 2014
Targeting a genetic defect: cystic fibrosis transmembrane conductance regulator modulators in cystic fibrosis Source: Eur Respir Rev 2013; 22: 58-65 Year: 2013
Targeting CFTR as a therapy for cystic fibrosis Source: Lung Science Conference 2010 - Biology of gene-environment interactions in the lung Year: 2010
Targeting cystic fibrosis inflammation in the age of CFTR modulators: focus on macrophages Source: Eur Respir J, 57 (6) 2003502; 10.1183/13993003.03502-2020 Year: 2021
Oral contraceptives do not appear to affect cystic fibrosis disease severity Source: Eur Respir J 2013; 41: 67-73 Year: 2013
LATE-BREAKING ABSTRACT: KCa3.1 ion channel-blockade reduces pulmonary fibrotic responses via the inhibition of fibroblast proliferation Source: International Congress 2016 – Common mechanisms in lung development and fibrosis Year: 2016
MRI detects changes in structure and perfusion, and response to therapy in early cystic fibrosis lung disease Source: International Congress 2014 – Cystic fibrosis: basic science, physiology and clinical aspects Year: 2014
Differences in airway inflammation between children with primary ciliary dyskinesia (PCD) and cystic fibrosis (CF) Source: International Congress 2014 – Cystic fibrosis: genotypes, inflammation and microbiology Year: 2014
Antiviral activity of azithromycin in cystic fibrosis airway epithelial cells Source: International Congress 2014 – Cystic fibrosis: assessment and treatment Year: 2014
SH2 domain-containing phosphatase-SHP-2 is a novel anti-fibrotic regulator in pulmonary fibrosis Source: International Congress 2016 – Emerging concepts in lung disease pathogenesis Year: 2016
Novel antiviral properties of vitamin D in cystic fibrosis airway epithelial cells Source: International Congress 2014 – Cystic fibrosis: assessment and treatment Year: 2014